Legal Research

GAPELESS Trademark Opposition Extension Request - Gap v. Ufeli Ani

Gap (Apparel), LLC has filed a first 90-day extension request with the USPTO Trademark Trial and Appeal Board to oppose Ufeli Ani's application to register the trademark GAPELESS. The extension was filed on April 24, 2026 under proceeding TTAB99307611. This procedural filing allows Gap additional time to prepare and file a formal notice of opposition against the GAPELESS mark.

ULTRA DENTAL Opposition TTAB91295913 - Motion to Compel Discovery

Ultradent Products, Inc. filed a Motion to Compel Discovery in TTAB Opposition proceeding TTAB91295913 against Ultra Dental Holdings LLC regarding the ULTRA DENTAL trademark. The opposition was originally filed on December 23, 2024, and the motion to compel was filed as of April 24, 2026. This procedural enforcement motion seeks to compel the defendant to respond to outstanding discovery requests in the trademark opposition proceeding before the USPTO Trademark Trial and Appeal Board.

National Board of Public Health Examiners TTAB Ex Parte Appeal

The National Board of Public Health Examiners (Washington, D.C.) filed Ex Parte Appeal TTAB99140670 with the USPTO Trademark Trial and Appeal Board on April 24, 2026. The appeal challenges a prior trademark determination and seeks review by the TTAB under case number 99140670. The case has been docketed as an EXA (Ex Parte Appeal) matter, with the original document viewable through the USPTO TTABVue system.

TTAB Opposition Dismissed: Jones Soda Co. v. HC Jones, Inc. — QUIT WITH JONES

The Trademark Trial and Appeal Board issued a final decision on April 24, 2026 dismissing Opposition No. TTAB91291502 with prejudice. Jones Soda Co. (USA) Inc. had challenged HC Jones, Inc.'s application to register the trademark QUIT WITH JONES, filed on May 15, 2024. The dismissal with prejudice bars Jones Soda from refiling the same opposition claim against the mark. The decision does not address the merits of likelihood-of-confusion analysis.

SOOTHE Extension: Bausch + Lomb Ireland Limited v Inspecs Limited

Bausch + Lomb Ireland Limited has filed a first 90-day extension request to oppose the trademark application for SOOTHE, filed by Inspecs Limited, with the USPTO Trademark Trial and Appeal Board. The extension request, bearing proceeding number TTAB79437386, was filed on April 24, 2026. This procedural filing extends the timeline for the opposing party to file a notice of opposition against the SOOTHE trademark application.

ENTREPRENEUR BABY Opposition Dismissed, April 24

The TTAB issued a final decision in opposition proceeding 91287109, dismissing Entrepreneur Media LLC's opposition against Mirjam Sommerfeld and Florian Sommerfeld's ENTREPRENEUR BABY trademark application without prejudice. The opposition, filed on September 11, 2023, was decided on April 24, 2026. Parties retain rights to refile or pursue other remedies.

Leaf Brands LLC v. Sarah Berger - ASTROEATS Opposition

Leaf Brands LLC has filed Trademark Opposition No. TTAB91294590 against Sarah Berger's ASTROEATS trademark application before the USPTO Trademark Trial and Appeal Board. The opposition was filed on October 16, 2024, and the defendant subsequently filed a motion to suspend the proceeding with consent, pending settlement negotiations. The case remains at an early procedural stage with no substantive determination on the merits of the opposition.

Studio Mir TTAB Appeal #90310822 Affirmed

The Trademark Trial and Appeal Board issued a final decision affirming Ex Parte Appeal #90310822 filed by Studio Mir Co., Ltd. The appeal, originally filed on 2025-07-01, was decided on 2026-04-24. This TTAB decision represents a final adjudication of the trademark matter and concludes the appellate review process for the named appellant.

NATIVE NATURE First 30-Day Extension to Oppose

Native Canada Footwear Ltd. filed a first 30-day request to extend the time to oppose the trademark NATIVE NATURE (owned by Integrated Brand Communications Inc.) before the USPTO Trademark Trial and Appeal Board. The extension request was filed on April 24, 2026 under TTAB case number TTAB99247747. This procedural filing does not itself decide the merits of any trademark claim but grants additional time for the opposer to prepare and file a formal notice of opposition.

Flow Beverages Inc v Metabev LLC Trademark Opposition

USPTO Trademark Trial and Appeal Board docket entry for Opposition No. 91282395 filed December 19, 2022, reflecting that proceedings have resumed in the trademark opposition between Flow Beverages Inc. and Metabev LLC concerning the FLOW mark. The opposition remains pending before the TTAB as an adversarial proceeding to determine whether Metabev LLC should be permitted to register the FLOW trademark.

Tobacco and Vaporisers Control (Specified Premises) Regulations 2026

The Ministry of Health Singapore has published S 243, subsidiary legislation specifying premises designated as controlled under Part 3B of the Tobacco and Vaporisers Control Act 1993. The Regulations take effect on 1 May 2026 and designate premises listed in the Schedule as specified premises for tobacco and vaporiser control purposes. Operators of affected premises should prepare for new compliance obligations by the effective date.

Public Defenders Act 2022 (Amendment of Schedule) Order 2026

The Public Defenders Act 2022 (Amendment of Schedule) Order 2026 (S 247), made by the Ministry of Law on 21 April 2026 and published on 24 April 2026, updates the Schedule to the Public Defenders Act 2022 by replacing item 35 in Part 3. The amendment reflects the renaming of the Tobacco (Control of Advertisements and Sale) Act 1993 to the Tobacco and Vaporisers Control Act 1993. The Order takes effect on 1 May 2026 and is to be presented to Parliament under section 8(5) of the Public Defenders Act 2022.

Constitution (Ministerial Responsibility) Amendment Notification 2026 — Ninth Schedule Paragraph (25)

The Constitution of the Republic of Singapore (Ministerial Responsibility) (Amendment) Notification 2026 (S 245) amends the Ninth Schedule of the 2025 Notification by replacing paragraph (25) under item 4 'Subjects' with a reference to the Tobacco and Vaporisers Control Act 1993. The amendment is issued under Article 30 of the Constitution by the Prime Minister and was made on 20 April 2026. It comes into operation on 1 May 2026.

Tobacco and Vaporisers Control (Appearance, Packaging and Labelling) (Amendment) Regulations 2026

The Tobacco (Control of Advertisements and Sale) (Appearance, Packaging and Labelling) (Amendment) Regulations 2026 (S 241/2026) expand the scope of the principal Regulations 2019 to include vaporisers in addition to tobacco products. The amendments substitute 'Tobacco (Control of Advertisements and Sale)' with 'Tobacco and Vaporisers Control' throughout the principal Regulations. Regulation 28(1) is amended to expand sub-paragraphs defining when tobacco or vaporiser products are deemed 'in the course of business' to include products offered for sale, transported, sent, delivered, or distributed within Singapore, or in a person's possession for the purpose of sale or distribution. Regulations 29 and 30 similarly replace sub-paragraph (b). The Regulations were made on 21 April 2026 by the Minister for Health under section 37 of the Tobacco and Vaporisers Control Act 1993 and come into operation on 1 May 2026.

Tobacco and Vaporisers Control (Specified Psychoactive Substances) (Authorisation) Regulations 2026

The Tobacco and Vaporisers Control (Specified Psychoactive Substances) (Authorisation) Regulations 2026 (S 242) authorize consumption of specified psychoactive substances under the Tobacco and Vaporisers Control Act 1993, effective 1 May 2026. Despite the general prohibition in section 19E, a person may consume specified psychoactive substances for medical or dental purposes provided the substance is not consumed using a Part 3A product (vaporiser/tobacco product) and consumption occurs either through administration by or under directions of a registered medical practitioner, registered dentist, or collaborative prescribing practitioner. Made on 21 April 2026 by the Ministry of Health, Singapore, and to be presented to Parliament under section 37(4) of the Act.

Active Mobility T100 Shared Paths Temporary Discontinuation Order 2026

The Land Transport Authority of Singapore has made the Active Mobility (Shared Paths — Temporary Discontinuation) (Singapore T100) Order 2026 under section 7 of the Active Mobility Act 2017. The order temporarily discontinues specified shared paths delineated by black-coloured lines in the Schedule on two dates: 25 April 2026 from 8 a.m. to 8 p.m., and 26 April 2026 from 4 a.m. to 6 p.m. The order was made on 24 April 2026 by LTA Chairperson Chan Heng Loon Alan. Users of active mobility devices such as bicycles, e-scooters, and personal mobility aids who normally travel on affected shared paths must seek alternative routes during the specified hours on both dates.

Interpretation (Delegations by Minister for Health) (Amendment) Order 2026

The Interpretation (Delegations by Minister for Health) (Amendment) Order 2026 amends the Second Schedule of the Interpretation (Delegations by Minister for Health) Order 2024, replacing the reference to the Tobacco (Control of Advertisements and Sale) Act 1993 with the Tobacco and Vaporisers Control Act 1993 in item 3. This amendment takes effect on 1 May 2026 and was made on 21 April 2026 by LAI WEI LIN, Permanent Secretary (Policy and Development), Ministry of Health. The amendment reflects the renaming of the principal legislation governing tobacco and vaporiser control in Singapore.

Active Mobility (Footpaths — Temporary Discontinuation) (Singapore T100) Order 2026

The Land Transport Authority of Singapore has made the Active Mobility (Footpaths — Temporary Discontinuation) (Singapore T100) Order 2026 under section 7 of the Active Mobility Act 2017, published in Subsidiary Legislation Supplement No. S 248 on 24 April 2026. The Order temporarily discontinues specific footpaths delineated in Map 1, Map 2, and Map 3 in the First Schedule, with dates and hours specified in the Second Schedule. Affected footpaths along the Singapore T100 route will be closed to pedestrians, cyclists, and personal mobility device users during the stated periods.

Active Mobility (Pedestrian-Only Paths — Temporary Discontinuation) (Singapore T100) Order 2026

The Land Transport Authority of Singapore has issued the Active Mobility (Pedestrian-Only Paths — Temporary Discontinuation) (Singapore T100) Order 2026 (No. S 249), made under section 7 of the Active Mobility Act 2017. The Order temporarily discontinues specified pedestrian-only paths delineated in the Schedule for the Singapore T100 event on 25 April 2026 from 8 a.m. to 8 p.m. and on 26 April 2026 from 4 a.m. to 6 p.m. The Order was made on 24 April 2026 by CHAN HENG LOON ALAN, Chairperson, LTA Singapore.

Medizinische Hochschule Hannover AAV2 Gene Therapy Vector Patent

The European Patent Office published patent application EP4107257A1, filed by Medizinische Hochschule Hannover, covering a viral vector particle based on AAV2 for gene therapy. The application names Thomas THUM, Hildegard BÜNING, Laura SANTER, and Christian BÄR as inventors. Classification spans C12N 7/00, C12N 15/864, and C07K 14/005. The application designates 31 European contracting states including Germany, France, the United Kingdom, and other EU member states.

Ivexsol Stable Viral Vector, EP4150097A1

Ivexsol, Inc. has been granted European Patent EP4150097A1 for compositions and methods of producing stable viral vector producer cells used in cell and gene therapy. The patent names Michael Greene as the sole inventor and covers viral vector technology intended to improve stability in cell and gene therapy manufacturing. The patent application designated multiple European states including Germany, France, the United Kingdom, and other EU member states.

Lymphocyte Population and Methods for Producing Same

The European Patent Office published patent application EP4110902A1 titled "Lymphocyte Population and Methods for Producing Same" on April 15, 2026. The application, filed by AVM Biotechnology, LLC of the United States, names inventors Theresa Deisher and Scot Wayne McKay. The invention is classified under IPC codes C12N 5/0783 and A61K 31/573, covering lymphocyte populations and production methods. The application designates all contracting states under the European patent system.

RegenxBio Inc. - EP4096631A1 Treatment of Mucopolysaccharidosis II With Recombinant Human Iduronate-2-Sulfatase Produced by Human Neural or Glial Cells

RegenxBio Inc. published European patent application EP4096631A1 on 15 April 2026 for a treatment method of Mucopolysaccharidosis II using recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells. The application names three inventors and is published under kind code A1, indicating a European patent application with search report. The application covers 34 designated contracting and extension states across the European Patent Organisation.

Sperm Picking System EP4103926A1

Smart-Pick GmbH filed patent application EP4103926A1 titled 'Sperm Picking System' with inventor KOSA, Gabor. The application was published by the European Patent Office on April 15, 2026. The invention is classified under multiple IPC categories including G01N 15/14, B01L 3/00, C12N 5/071, G01N 21/84, and G06K 9/00, indicating applications in image analysis, microfluidic devices, cell processing, and artificial intelligence for sperm selection.

MedImmune CAR Therapy Compositions and Methods for Treating Cancer, EP4138887A1

MedImmune, LLC has filed European patent application EP4138887A1 for compositions and methods of treating cancer using chimeric antigen receptors (CARs). The application was published by the European Patent Office on April 15, 2026, and lists five inventors: Gordon Moody, Maria Letizia Giardino Torchia, Michael Glen Overstreet, and Ryan Gilbreth. The filing is classified under A61K 39/00, C12N 5/0783, C12N 15/87, and A61P 35/00, and designates all EPC contracting states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Production Method for Retinal Tissue, EP3868873A1, Apr 15

The European Patent Office published patent EP3868873A1 titled 'Production Method for Retinal Tissue' on April 15, 2026. The patent names RACTHERA Co., Ltd. and RIKEN as applicants, with inventors including KUWAHARA, Atsushi, YAMASAKI, Suguru, HIRAMINE, Yasushi, SASAI, Yoshiki, and TAKAHASHI, Masayo. IPC classifications include C12N 5/079 (cell or tissue culture), A61K 35/44 (eye-related preparations), A61L 27/00 (prosthetic implants), and A61P 27/02 (ophthalmic agents).

Viral Respiratory Infection Treatment Methods, Gradalis, Inc., EP4158025A1

The European Patent Office published application EP4158025A1 for Gradalis, Inc. on April 15, 2026. The patent covers methods for treating viral respiratory infections using nucleic acid sequences classified under C12N 15/113, with pharmaceutical compositions containing A61K 38/19 and A61K 31/713. The application designates 31 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR. Inventors include David Shanahan, John Nemunaitis, and Ernest Bognar.

Brandy Rose Jones v. Jackson Public School District - FMLA Complaint, IFP Denied

United States District Court for the Southern District of Mississippi issued an order on April 24, 2026, in Brandy Rose Jones v. Jackson Public School District (Civil Action No. 3:26-cv-162-KHJ-MTP), adopting Magistrate Judge Michael T. Parker's Report and denying the plaintiff's multiple motions to proceed in forma pauperis. The court found that Jones received over $20,000 in income in March 2026 from tax refunds, emergency retirement withdrawals, child support, and public assistance, making it not an undue hardship to pay the filing fee. Jones is ordered to pay the filing fee within 60 days or the case will be dismissed without further notice.

Brookshire Grocery Company v. Lindsey-Pine Plaza LLC - Motion for Reconsideration Denied

The US District Court for the Western District of Arkansas denied a Motion for Reconsideration filed by Lindsey-Pine Plaza LLC under Rule 54(b), affirming its prior summary judgment ruling that the landlord is obligated to pay for structural repairs under the parties' lease agreement. The court rejected Lindsey-Pine's argument that whether Brookshire's use exceeded ordinary wear and tear presented a disputed fact question for trial, finding instead that the lease unambiguously requires the landlord to pay for structural repairs regardless of causation. The underlying dispute remains unresolved on damages.

Haylee Christyne Kelly v. Grace Family Partnership, et al. - Dismissal with Prejudice

Haylee Christyne Kelly filed a pro se civil action in July 2025 alleging a conspiracy across state, federal, corporate, and technological entities involving identity theft, biometric data exploitation, and interference with legacy estate rights. The plaintiff asserted claims under 42 U.S.C. § 1983 (Due Process and Equal Protection), the Computer Fraud and Abuse Act (18 U.S.C. § 1030(g)), RICO (18 U.S.C. §§ 1961–1968), and the Declaratory Judgment Act (28 U.S.C. §§ 2201–2202). The Magistrate Judge recommended dismissal with prejudice under 28 U.S.C. § 1915(e)(2)(B) on April 1, 2026; the District Court adopted this recommendation on April 24, 2026. All claims were dismissed for failure to state viable legal claims.

Bell v. State of Louisiana - Federal Claims Dismissed With Prejudice

The United States District Court for the Middle District of Louisiana adopted the Magistrate Judge's Report and Recommendation in Bell v. State of Louisiana, dismissing plaintiff Steven Bell's federal claims under 42 U.S.C. § 1983 with prejudice as legally frivolous and for failure to state a claim. The Court also declined to exercise supplemental jurisdiction over potential state law claims and denied as moot Bell's subsequent motion for immediate release. No party filed objections to the Magistrate Judge's report.

Walberto Hernandez-Reyes v. Master Donuts, Inc. — ADA Accessibility Barriers

In Walberto Hernandez-Reyes v. Master Donuts, Inc., the U.S. District Court for the District of Puerto Rico held Defendant's Motion to Dismiss in abeyance, finding that the mootness challenge requires consideration of matters outside the pleadings and is intertwined with the merits. The Court will evaluate the motion under Fed. R. Civ. P. 56 summary judgment standard after the record is further developed. Defendant's request to declare Plaintiff and his counsel vexatious litigants was denied without prejudice. The Second Amended Complaint alleges four architectural ADA violations at the donut shop: an entrance ramp with excessive slope, a noncompliant accessible parking space and access aisle, an inaccessible counter section with inadequate knee and toe clearance, and an inaccessible customer restroom due to a trash receptacle blocking required clear floor space.

EP4157880A2 - Osteoarthritis Treatment Methods and Compositions

The EPO published European patent application EP4157880A2, filed by the New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery, covering methods and compositions for treating, preventing the onset, and/or slowing the progression of osteoarthritis. The application names Miguel Otero Adran and Purva Singh as inventors and lists IPC classifications C07K 16/28, C07K 16/30, A61K 39/395, and A61K 47/68, indicating pharmaceutical compositions including antibodies and antibody-drug conjugates. The publication designates all European patent contracting states, establishing a priority date for the disclosed therapeutic approach.

Dual Promoter Systems - Seattle Children's Hospital - EP4149966A1

The European Patent Office published European patent application EP4149966A1 titled 'Dual Promoter Systems' on 15 April 2026. The applicant is Seattle Children's Hospital (DBA Seattle Children's Research Institute) and the inventors are Michael C. Jensen and Jia Wei. The application covers C07K peptide sequences classified under IPC codes C07K 14/705 and C07K 19/00, with designations extending across 31 European states including DE, FR, GB, NL, and SE.

Vigil Neuroscience TREM2 Agonists ATP Transporter 1 Patent EP4255567A1

The European Patent Office published patent application EP4255567A1 for Vigil Neuroscience, Inc., covering TREM2 agonists for the treatment of diseases related to ATP-binding cassette transporter 1 dysfunction. The patent names inventors Papapetropoulos, Fisher, and Brennan, with applications extending to neurological conditions including Alzheimer's and Parkinson's diseases. The patent designates 35 Contracting States for protection.

Chrysalis Biotherapeutics TP508 Acute Respiratory Virus Therapy Patent EP4132948A1

The European Patent Office published patent application EP4132948A1 titled 'TP508 Acute Therapy for Patients with Respiratory Virus Infection' on April 15, 2026. The patent application covers peptide-based therapeutic compositions and lists Chrysalis Biotherapeutics as the applicant with inventors Darrell Carney and Laurie Sower. The designated states for potential validation include all EPC contracting states across the European region. Patent publication does not constitute market authorization or clinical approval for the therapeutic indication described.

Biologically Active Conjugate Patent, D&D Pharmatech

The EPO published European patent application EP4252780A1 for D&D Pharmatech Inc. on April 15, 2026, covering a biologically active material conjugate with a biotin moiety, fatty acid moiety, or combination thereof. The application lists inventors SHIN Jae hee, LIM Sung Mook, and PARK Eun Ji, with classifications spanning A61K 47/54, A61K 38/00, A61K 38/16, A61K 9/00, A61K 38/26, A61K 47/55, and C07K 14/605. The patent is designated across 38 European and Patent Cooperation Treaty states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Sweden, and 31 additional countries.

Bispecific Antibodies CD47 Treatment, Published 15th Apr

The European Patent Office published application EP4139364A1 on 15 April 2026, covering bispecific antibodies for treating CD47-associated diseases. Virtuoso Binco, Inc. is the applicant, with WANG, Xinhua, CHEN, Xiaocheng, SHI, Lei, POST, Leonard, and WONG, Oi Kwan listed as inventors. The application covers the CD47 pathway targeting mechanism and is classified under multiple IPC codes including C07K 16/46 and C07K 16/28. This patent provides intellectual property protection across all designated European member states including Germany, France, the United Kingdom, and 29 other designated states.

Fusion Proteins With Specificity for Type II Collagen and VEGF-A for the Treatment of Eye Diseases

The EPO published European patent application EP4326764A1, filed by Navigo Proteins GmbH, covering fusion proteins with specificity for type II collagen and VEGF-A for the treatment of eye diseases. The application names inventors Bosse-Doenecke, Eva; Gloser-Braeunig, Manja; Katzschmann, Anja; and Haupts, Ulrich. The patent is classified under C07K 16/22, C07K 14/78, and A61P 27/02, with all EPC contracting states designated.

Tumor Immune Enhancer Patent EP4112636A1 Published by EPO

The European Patent Office published patent application EP4112636A1 titled 'Tumor Immune Enhancer, And Preparation Method Therefor And Application Thereof' on April 15, 2026. The applicant is Wuxi Plb Therapeutics Technology Limited. Co, with inventors DENG, Li, CHEN, Shuxian, QU, Xiuxia, and GONG, Xiaohai. The technology is classified under IPC codes C07K 14/195 (peptides), C12N 15/31 (biotechnology/nucleic acids), A61K 39/39 (immunological preparations), and A61P 35/00 (antineoplastic agents). The patent has been designated across 30 European member states including AT, BE, DE, ES, FR, GB, IT, NL, and PL.

Green Cross Corp EP4242224A1 Coronavirus Spike Protein Antibody Patent

Green Cross Corporation and Mogam Institute for Biomedical Research have obtained EPO publication EP4242224A1 for an antibody specific to coronavirus spike protein, classified under IPC C07K 16/10 and A61P 31/14. The patent names 13 inventors: Dong-Sik Kim, Sua Lee, Shin A Jang, Jihoon Kang, Ki Joon Cho, Soo Bin Park, Young Woo Han, Hyemi Nam, Mi Young Oh, Jee Boong Lee, Jihye Ryu, Mun Kyung Kim, and Jeewon Lee. The designated states cover 35 European contracting states including Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, and other EU/EEA jurisdictions.

Engineered T Cell Receptors and Methods of Use, University of Texas System, EP4161555A1

The European Patent Office published application EP4161555A1 titled 'Engineered T Cell Receptors and Methods of Use' on April 15, 2026. The applicants are the Board of Regents, The University of Texas System, with inventors Yee, Cassian and PAN, Ke listed. The patent covers engineered T cell receptors and methods of use, classified under IPC codes including A61K 38/00, C07K 14/725, C07K 19/00, and C12N 15/62. This publication makes the application publicly available and initiates the opposition period in designated European states.

Multispecific Chimeric Antigen Receptors Patent EP4182356A1

The EPO published European Patent Application EP4182356A1 for multispecific chimeric antigen receptors (CARs) and uses thereof, filed by Legend Biotech Ireland Limited and Legend Biotech USA Inc. The patent application names FAN Xiaohu, ZHOU Zhe, and PAN Hongbo as inventors, and covers compositions and methods for cancer treatment. The application is classified under eight IPC codes spanning hybrid proteins, T-cell receptors, antibodies, and therapeutic applications. Designated states include thirty-two European countries and territories including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Kappa Opioid Receptor Agonist KTAC Compounds Patent Application EP4157308A2

The European Patent Office published patent application EP4157308A2 for Kappa Opioid Receptor Agonist-Therapeutic Antigen Binding Protein Conjugate (KTAC) compounds on April 15, 2026. The application, filed by Cara Therapeutics, Inc. with inventors Chalmers and Lewis, covers pharmaceutical compositions related to A61K and C07K classifications. Designated states include all EPO member states across the European Patent Convention region.

Sparhawk LLC, et al., Woodtrust Bank Abstention Motion Denied

The United States Bankruptcy Court for the Western District of Wisconsin denied WoodTrust Bank's motion seeking abstention from and dismissal of Chapter 11 cases filed by Sparhawk LLC and three related entities. The court conducted four days of evidentiary hearings on the motion before issuing its ruling. The debtors, who operate a transportation and logistics business with approximately 200 trucks and 1,000 trailers, faced financial distress stemming from a train derailment lawsuit, mechanical failures, and the manager's extended medical absence. The case will proceed under Chapter 11 protection despite the Bank's efforts to have it dismissed or sent to state court receivership.

Sparhawk LLC Chapter 11 Trustee Motion Granted

The United States Bankruptcy Court for the Western District of Wisconsin granted WoodTrust Bank's motion to appoint a Chapter 11 Trustee for Sparhawk LLC, Sparhawk Properties LLC, Sparhawk Trucking, Inc., and Sparhawk Truck and Trailer, Inc. under 11 U.S.C. § 1104(a)(2). The Court found the appointment is in the best interests of creditors, equity security holders, and other estate interests. The court ordered the appointment of a Chapter 11 Trustee by the United States Trustee as soon as possible, while denying the Bank's motion to abstain from or dismiss the cases. The debtors, who operate a transportation and logistics business with over 100 trucks, had experienced cash flow problems, gaps in financial records, and management issues following the manager's medical problems in 2023.

Christopherson v. Polovinka - Summary Judgment Granted on Negligence Claims from I-79 Collision

The US District Court for the Western District of Pennsylvania granted summary judgment to Defendants Nikolay Polovinka and R&M Transportation Inc. in Heber J. Christopherson's negligence suit arising from a June 11, 2023 collision on Interstate 79 in Greenwood Township, Pennsylvania. The Court found that Pennsylvania State Police determined Mr. Polovinka did not violate any traffic rules, while Mr. Christopherson violated 75 Pa. C.S.A § 3309(1) by failing to maintain proper lane position. Plaintiff conceded Count III (negligent hiring/training/supervision) should be dismissed and does not appeal. The grant of summary judgment disposes of all remaining negligence claims against the defendants.

Higgins v. Lane - Deed in Lieu of Foreclosure Validity Ruling

The United States Bankruptcy Court for the Northern District of West Virginia denied the motion for partial summary judgment filed by Patrick Higgins and Chapter 13 Trustee Ryan W. Johnson, while granting the counter motion filed by defendant Mary Robinson. The Court determined that a deed in lieu of foreclosure executed between debtor Patrick Higgins and Ronald O. Lane is valid and enforceable, rejecting the plaintiffs' claim that the deed lacked post-default consideration. This ruling resolves the adversary proceeding No. 1:23-ap-4 and establishes findings of fact and conclusions of law on the validity of the deed in lieu of foreclosure transaction.

Trevor Covert v. Media Intercept, Inc. — Case Transferred to Middle District of Florida

The United States District Court for the District of Idaho granted Defendant Media Intercept, Inc.'s Motion to Dismiss on April 24, 2026, finding that personal jurisdiction was lacking in Idaho. The court ordered the case transferred to the Middle District of Florida. Plaintiff Trevor Covert, an Idaho resident who worked remotely from Idaho as Director of Sales, had brought state law claims including breach of contract, unjust enrichment, and promissory estoppel arising from unpaid commissions following his April 30, 2025 termination. Defendant Media Intercept is incorporated in Florida with its principal place of business in Orlando. The court applied Idaho's long-arm statute and federal due process standards in reaching its jurisdictional determination.

Chapman v. United States - Court Denies Habeas Corpus Petition

The US District Court for the District of Idaho denied Plaintiff Khadijah X. Chapman's Petition for Writ of Habeas Corpus Pursuant to 28 U.S.C. § 2255 and Motion to Compel a Ruling. Chapman challenged her 2023 bank fraud conviction and 46-month sentence on grounds including ineffective assistance of counsel and denial of her motion to substitute counsel. The Court applied the Strickland v. Washington two-prong test for ineffective assistance of counsel and found the petition lacked merit, dismissing the motion as moot.